These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38171993)

  • 1. "Pre-Histologic" Antibody-Mediated Rejection Detected by Donor-Derived Cell-Free DNA and a Novel Tissue Gene Expression Assay: A Case Report.
    Ruder T; Reddy NA; Zhang H; Zhou XJ; Curtis A; Madhrira MM; Reyad AI; Shekhtman G; Allam SR
    Transplant Proc; 2024; 56(1):236-238. PubMed ID: 38171993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Trifecta Study: Comparing Plasma Levels of Donor-derived Cell-Free DNA with the Molecular Phenotype of Kidney Transplant Biopsies.
    Halloran PF; Reeve J; Madill-Thomsen KS; Demko Z; Prewett A; Billings P;
    J Am Soc Nephrol; 2022 Feb; 33(2):387-400. PubMed ID: 35058354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donor-derived cell-free DNA (dd-cfDNA) for detection of allograft rejection in pediatric kidney transplants.
    Puliyanda DP; Swinford R; Pizzo H; Garrison J; De Golovine AM; Jordan SC
    Pediatr Transplant; 2021 Mar; 25(2):e13850. PubMed ID: 33217125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combining Blood Gene Expression and Cellfree DNA to Diagnose Subclinical Rejection in Kidney Transplant Recipients.
    Park S; Guo K; Heilman RL; Poggio ED; Taber DJ; Marsh CL; Kurian SM; Kleiboeker S; Weems J; Holman J; Zhao L; Sinha R; Brietigam S; Rebello C; Abecassis MM; Friedewald JJ
    Clin J Am Soc Nephrol; 2021 Oct; 16(10):1539-1551. PubMed ID: 34620649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early clinical experience using donor-derived cell-free DNA to detect rejection in kidney transplant recipients.
    Huang E; Sethi S; Peng A; Najjar R; Mirocha J; Haas M; Vo A; Jordan SC
    Am J Transplant; 2019 Jun; 19(6):1663-1670. PubMed ID: 30725531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between donor-derived cell-free DNA and tissue-based rejection-related transcripts in heart transplantation.
    Lee DH; Usmani A; Wu R; Wicks T; Noh CY; Burke R; Ravichandran V; Wolf-Doty T; Dumitru I; Oliveira GH; Berman P; Mackie B
    J Heart Lung Transplant; 2024 Jul; 43(7):1118-1125. PubMed ID: 38373559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcomes from the Assessing Donor-derived cell-free DNA Monitoring Insights of kidney Allografts with Longitudinal surveillance (ADMIRAL) study.
    Bu L; Gupta G; Pai A; Anand S; Stites E; Moinuddin I; Bowers V; Jain P; Axelrod DA; Weir MR; Wolf-Doty TK; Zeng J; Tian W; Qu K; Woodward R; Dholakia S; De Golovine A; Bromberg JS; Murad H; Alhamad T
    Kidney Int; 2022 Apr; 101(4):793-803. PubMed ID: 34953773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic Performance of Donor-Derived Plasma Cell-Free DNA Fraction for Antibody-Mediated Rejection in Post Renal Transplant Recipients: A Prospective Observational Study.
    Zhang H; Zheng C; Li X; Fu Q; Li J; Su Q; Zeng L; Liu Z; Wang J; Huang H; Xu B; Ye M; Liu L; Wang C
    Front Immunol; 2020; 11():342. PubMed ID: 32184785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value of donor-derived cell-free DNA to predict antibody-mediated rejection in donor-specific antibody-positive renal allograft recipients.
    Mayer KA; Doberer K; Tillgren A; Viard T; Haindl S; Krivanec S; Reindl-Schwaighofer R; Eder M; Eskandary F; Casas S; Wahrmann M; Regele H; Böhmig GA
    Transpl Int; 2021 Sep; 34(9):1689-1702. PubMed ID: 34448270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Observed elevated donor-derived cell free DNA in orthotopic heart transplant recipients without clinical evidence of rejection.
    Afzal A; Alam A; van Zyl JS; Zafar H; Felius J; Hall SA; Carey SA
    Clin Transplant; 2022 Mar; 36(3):e14549. PubMed ID: 34863042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of a donor-derived cell-free DNA assay to monitor treatment response in pediatric renal transplant recipients with allograft rejection.
    Steggerda JA; Pizzo H; Garrison J; Zhang X; Haas M; Kim IK; Jordan SC; Puliyanda DP
    Pediatr Transplant; 2022 Jun; 26(4):e14258. PubMed ID: 35340104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combining donor-derived cell-free DNA and donor specific antibody testing as non-invasive biomarkers for rejection in kidney transplantation.
    Obrișcă B; Butiu M; Sibulesky L; Bakthavatsalam R; Smith KD; Gimferrer I; Warner P; Ismail G; Leca N
    Sci Rep; 2022 Sep; 12(1):15061. PubMed ID: 36064740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noninvasive detection of graft injury after heart transplant using donor-derived cell-free DNA: A prospective multicenter study.
    Khush KK; Patel J; Pinney S; Kao A; Alharethi R; DePasquale E; Ewald G; Berman P; Kanwar M; Hiller D; Yee JP; Woodward RN; Hall S; Kobashigawa J
    Am J Transplant; 2019 Oct; 19(10):2889-2899. PubMed ID: 30835940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated fractional donor-derived cell-free DNA during subclinical graft injury after liver transplantation.
    Baumann AK; Beck J; Kirchner T; Hartleben B; Schütz E; Oellerich M; Wedemeyer H; Jaeckel E; Taubert R
    Liver Transpl; 2022 Dec; 28(12):1911-1919. PubMed ID: 35429207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Donor-derived cell-free DNA detects kidney transplant rejection during nivolumab treatment.
    Hurkmans DP; Verhoeven JGHP; de Leur K; Boer K; Joosse A; Baan CC; von der Thüsen JH; van Schaik RHN; Mathijssen RHJ; van der Veldt AAM; Hesselink DA
    J Immunother Cancer; 2019 Jul; 7(1):182. PubMed ID: 31300068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic Response of Donor-Derived Cell-Free DNA Following Treatment of Acute Rejection in Kidney Allografts.
    Wolf-Doty TK; Mannon RB; Poggio ED; Hinojosa RJ; Hiller D; Bromberg JS; Brennan DC
    Kidney360; 2021 Apr; 2(4):729-736. PubMed ID: 35373051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protocol-based donor-derived cell-free DNA surveillance in kidney transplant recipients: A single-center experience.
    Nissaisorakarn P; Patel H; Amtul A; Pavlakis M
    Clin Nephrol; 2022 Aug; 98(2):65-74. PubMed ID: 35445660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absolute quantification of donor-derived cell-free DNA as a marker of rejection and graft injury in kidney transplantation: Results from a prospective observational study.
    Oellerich M; Shipkova M; Asendorf T; Walson PD; Schauerte V; Mettenmeyer N; Kabakchiev M; Hasche G; Gröne HJ; Friede T; Wieland E; Schwenger V; Schütz E; Beck J
    Am J Transplant; 2019 Nov; 19(11):3087-3099. PubMed ID: 31062511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donor-Derived Cell-Free DNA (dd-cfDNA) in Kidney Transplant Recipients With Indication Biopsy-Results of a Prospective Single-Center Trial.
    Benning L; Morath C; Fink A; Rudek M; Speer C; Kälble F; Nusshag C; Beimler J; Schwab C; Waldherr R; Zeier M; Süsal C; Tran TH
    Transpl Int; 2023; 36():11899. PubMed ID: 38020751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High levels of dd-cfDNA identify patients with TCMR 1A and borderline allograft rejection at elevated risk of graft injury.
    Stites E; Kumar D; Olaitan O; John Swanson S; Leca N; Weir M; Bromberg J; Melancon J; Agha I; Fattah H; Alhamad T; Qazi Y; Wiseman A; Gupta G
    Am J Transplant; 2020 Sep; 20(9):2491-2498. PubMed ID: 32056331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.